VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,726,783 | -35.0% | 151,565 | -36.4% | 0.00% | -33.3% |
| Q2 2023 | $11,892,662 | +704.0% | 238,139 | +503.4% | 0.00% | – |
| Q1 2023 | $1,479,261 | -86.0% | 39,468 | -82.1% | 0.00% | -100.0% |
| Q4 2022 | $10,560,460 | +1122.3% | 220,239 | +510.9% | 0.00% | – |
| Q3 2022 | $864,000 | +5.6% | 36,050 | -4.1% | 0.00% | – |
| Q2 2022 | $818,000 | +24.7% | 37,596 | +38.3% | 0.00% | – |
| Q1 2022 | $656,000 | +90.7% | 27,189 | +87.9% | 0.00% | – |
| Q4 2021 | $344,000 | -18.7% | 14,470 | -13.1% | 0.00% | – |
| Q3 2021 | $423,000 | +29.0% | 16,658 | +14.4% | 0.00% | – |
| Q2 2021 | $328,000 | – | 14,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $90,711,000 | 29.04% |
| Medicxi Ventures Management (Jersey) Ltd | 3,774,956 | $82,142,000 | 17.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 832,166 | $18,108,000 | 9.12% |
| GREAT POINT PARTNERS LLC | 985,153 | $21,437,000 | 5.14% |
| Kynam Capital Management, LP | 723,781 | $15,749,000 | 4.02% |
| Ghost Tree Capital, LLC | 325,000 | $7,072,000 | 3.68% |
| Frazier Life Sciences Management, L.P. | 1,787,405 | $38,894,000 | 3.67% |
| RA Capital Management | 4,581,203 | $99,687,000 | 2.66% |
| Opaleye Management Inc. | 190,000 | $4,134,000 | 1.86% |
| Soleus Capital Management, L.P. | 370,650 | $8,065,000 | 1.26% |